Selim Sancak

Dr. Selim Sancak

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2019 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
DADidem Arman
Didem Arman
SSSelim Sancak
Selim Sancak
TGTugba Gürsoy
Tugba Gürsoy
STSevilay Topcuoglu
Sevilay Topcuoglu
GKGüner Karatekin
Güner Karatekin
FOFahri Ovalı
Fahri Ovalı
Objective: To determine if near-infrared spectroscopy (NIRS), which is easier to obtain than Doppler ultrasonography (USG), may be used in accordance with Doppler USG to provide additional data for assessment of organ blood flow velocities in preterm infants with hemodynamically significant PDA. Study design: Thirty-one infants who were treated with ibuprofen for closure of PDA were monitored continuously with NIRS. Cerebral, mesenteric, and renal arterial blood flow velocities were measured with Doppler USG before and after the treatment. Results: While cerebral, mesenteric, and renal fractional oxygen extraction (FTOE) measurements decreased significantly (p = .042, p < .001, p < .001, respectively), NIRS measurements (p = .016, p < .001, p < .001, respectively) and mean blood flow velocities (p = .003, p = .011, p = .002, respectively) increased significantly after the treatment. There was a significant correlation between pretreatment cerebral and mesenteric FTOE and resistive index (RI) values (r = 0.45, p = .01, and r = 0.46, p = .01, respectively). However, no correlation was observed between renal FTOE values and renal RI (r = 0.33, p = .06). Posttreatment cerebral, renal, and mesenteric FTOE values correlated positively with corresponding RI (r = 0.41, p = .02; r = 0.39, p = .02; r = 0.65, p < 01; respectively). Pretreatment and posttreatment cerebral, mesenteric, and renal FTOE values and arterial mean velocities were inversely correlated (pretreatment: r = 0.69, p < .01; r = 0.72, p < .01; r = 0.77, p < .01; posttreatment: r = 0.54, p = .01; r = 0.69, p < .01; r = 0.38, p = .01; respectively). Conclusion: As Doppler and NIRS measurements correlated significantly, we concluded that NIRS might be used in monitoring organ blood flow in preterm infants with PDA, which may provide additional data for management of this condition.

29 February 2016 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
SSSelim Sancak
Selim Sancak
TGTugba Gursoy
Tugba Gursoy
GKGuner Karatekin
Guner Karatekin
FOFahri Ovali
Fahri Ovali

1 April 2019 in Retina
Verified
Journal Article
Closed access
SSSelim Sancak
Selim Sancak
HTHandan Hakyemez Toptan
Handan Hakyemez Toptan
TYTulin Gokmen Yildirim
Tulin Gokmen Yildirim
GKGuner Karatekin
Guner Karatekin
FOFahri Ovali
Fahri Ovali
Purpose: To study the association between thrombocytopenia and retinopathy of prematurity (ROP). Methods: The case-control study was conducted on preterm newborns with ROP between January 2011 and January 2014, retrospectively. The patients were assigned into two groups: Cases required intervention and controls developed no or Stage I ROP. Results: Eighty-one premature infants with Type I ROP were enrolled to the study with a mean gestational age of 27.6 ± 2.1 (range: 24–32) weeks and birth weight of 993 ± 292 (range: 560–1,930) g. Mean follow-up time was 38.3 ± 2.7 weeks (min: 32 and max: 46 weeks). Cases were individually matched to a set of controls (1:1 ratio). Thrombocytopenia (<150.000/mm3) was seen in 58 (71.6%) of the cases with Type I ROP, whereas only 17 (21%) of the controls had thrombocytopenia (P < 0.001). Logistic regression analysis showed that bronchopulmonary dysplasia and thrombocytopenia were significantly associated with Type I ROP (relative risk [95% confidence interval]: 4.19 [1.47–12] and 6.69 [2.83–15.9], respectively). The thrombocytopenia ratio (P = 0.073), thrombocytopenia 1 week before intervention (P = 0.076) and platelet transfusion ratio (P = 0.062) tended to be higher in Zone I ROP compared with Zone II ROP. Conclusion: In our study, there was a significant association between thrombocytopenia and Type I ROP.

25 April 2017 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
PDF file
SSSelim Sancak
Selim Sancak
ATAbdulhamit Tuten
Abdulhamit Tuten
TYTulin Gokmen Yildirim
Tulin Gokmen Yildirim
GKGuner Karatekin
Guner Karatekin

1 March 2024 in Therapeutic Hypothermia and Temperature Management
Verified
Journal Article
Closed access
EDEmre Dincer
Emre Dincer
STSevilay Topcuoglu
Sevilay Topcuoglu
ECElif Betul Keskin Cetinkaya
Elif Betul Keskin Cetinkaya
ÖAÖzge Yatır Alkan
Özge Yatır Alkan
EÖElif Özalkaya
Elif Özalkaya
GKGüner Karatekin
Güner Karatekin
Studies in infants with hypoxic-ischemic encephalopathy (HIE) due to perinatal asphyxia have generally focused on neurological outcomes. Although acute kidney injury (AKI) rate decreased in advent of therapeutic hypothermia (TH), it is still a common and important entity. In this retrospective study, we aimed to investigate the risk factors for AKI in HIE patients treated with hypothermia. Infants treated with TH due to HIE were reviewed retrospectively and infants who developed AKI and not were compared. Ninety-six patients were enrolled in the study. AKI developed in 27 (28%) patients and 4 (14.8%) of them were stage III AKI. In the AKI group, gestational age of the patients was significantly higher ( p = 0.035), the 1st minute Apgar score was significantly lower ( p = 0.042), and convulsions (p = 0.002), amplitude-integrated electroencephalography disorders ( p = 0.025), sepsis ( p = 0.017), need for inotropic therapy ( p = 0.001), need of invasive mechanical ventilation ( p = 0.03), and systolic dysfunction in echocardiography ( p = 0.022) were significantly higher. In logistic regression tests, Apgar score at the 1st minute was found to be independent risk factor for developing AKI. AKI has the potential to worsen the neurological damage and correlates with morbidities of perinatal asphyxia. It is important to determine the incidence and risk factors for developing AKI in this delicate group of patients to prevent further renal damage.

23 March 2017 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
SSSelim Sancak
Selim Sancak
TGTugba Gursoy
Tugba Gursoy
ATAbdulhamit Tuten
Abdulhamit Tuten
DADidem Arman
Didem Arman
GKGuner Karatekin
Guner Karatekin
FOFahri Ovali
Fahri Ovali
Purpose: To examine the prokinetic effect of clarithromycin in very low birth weight (VLBW) preterm infants. Materials and methods: VLBW preterm infants who have not achieved half of the full enteral feeding in the second week of life were enrolled in the study. The infants enrolled in the study were randomized. Twenty infants received oral clarithromycin (7.5 mg/kg, twice a day) and 20 control infants did not receive any treatment. Results: Full enteral feeding was attained earlier in the clarithromycin group than in the control group [7 (6–9) versus 9 (9–11) days, respectively; p < .001]. Duration of parenteral nutrition and number of withheld feeds were significantly lower in the clarithromycin group (p = .013 and p < .001, respectively). Parenteral nutrition-associated cholestasis (n = 1 versus 3, p = .1) and length of hospital stay (50 versus 59 median days, p = .1) tend to be lower in the clarithromycin group without any statistical significance. We observed no adverse effect of clarithromycin therapy. Conclusions: Clarithromycin treatment in VLBW preterm infants resulted in better toleration of enteral feeding. Larger randomized controlled trials are needed to establish routine use of clarithromycin in the treatment of feeding intolerance.